🇺🇸 FDA
Pipeline program

Yishen Qutong Granules

NCC4369

Unknown small_molecule active

Quick answer

Yishen Qutong Granules for Esophageal Squamous Cell Carcinoma (ESCC) is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Esophageal Squamous Cell Carcinoma (ESCC)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials